Position in NTLA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$12,982,889
+$4,609,685 QoQ
Shares Held
1,012,706
+8.7% QoQ
Ownership
0.725%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. NTLA ranks #9 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
9,940,885 | $84,099,887 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
161,052 | $71,916,158 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,907 | $37,787,502 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
139,514 | $26,375,120 | |
| 5 | OMER |
Omeros Corp
|
1,831,585 | $19,341,536 | |
| 6 | MANE |
Veradermics, Inc
|
294,117 | $18,573,488 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
49,954 | $16,528,277 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
196,703 | $14,770,427 |
All Filings in NTLA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,982,889 | 1,012,706 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $8,373,204 | 931,391 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,444,970 | 778,516 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $7,363,618 | 785,034 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,614,495 | 789,662 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,637,891 | 397,761 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,944,234 | 94,610 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,047,948 | 91,508 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,313,370 | 84,092 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,089,265 | 68,523 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $1,574,327 | 49,789 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,769,933 | 43,402 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,147,356 | 30,785 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,059,085 | 30,355 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,414,948 | 25,285 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,255,542 | 24,257 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,320,340 | 18,169 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,338,077 | 19,774 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,699,499 | 20,123 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,778,330 | 23,336 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,290,236 | 28,537 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $982,464 | 18,060 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||